1 DTaP and Tdap Vaccines Market Overview
1.1 Product Overview and Scope of DTaP and Tdap Vaccines
1.2 DTaP and Tdap Vaccines Segment by Type
1.2.1 Global DTaP and Tdap Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 DTaP
1.2.3 Td
1.2.4 Tdap
1.3 DTaP and Tdap Vaccines Segment by Application
1.3.1 DTaP and Tdap Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Adult
1.3.3 Pediatric
1.4 Global DTaP and Tdap Vaccines Market Size Estimates and Forecasts
1.4.1 Global DTaP and Tdap Vaccines Revenue 2016-2027
1.4.2 Global DTaP and Tdap Vaccines Sales 2016-2027
1.4.3 DTaP and Tdap Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

2 DTaP and Tdap Vaccines Market Competition by Manufacturers
2.1 Global DTaP and Tdap Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global DTaP and Tdap Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global DTaP and Tdap Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers DTaP and Tdap Vaccines Manufacturing Sites, Area Served, Product Type
2.5 DTaP and Tdap Vaccines Market Competitive Situation and Trends
2.5.1 DTaP and Tdap Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest DTaP and Tdap Vaccines Players Market Share by Revenue
2.5.3 Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 DTaP and Tdap Vaccines Retrospective Market Scenario by Region
3.1 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America DTaP and Tdap Vaccines Market Facts & Figures by Country
3.3.1 North America DTaP and Tdap Vaccines Sales by Country
3.3.2 North America DTaP and Tdap Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe DTaP and Tdap Vaccines Market Facts & Figures by Country
3.4.1 Europe DTaP and Tdap Vaccines Sales by Country
3.4.2 Europe DTaP and Tdap Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific DTaP and Tdap Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific DTaP and Tdap Vaccines Sales by Region
3.5.2 Asia Pacific DTaP and Tdap Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America DTaP and Tdap Vaccines Market Facts & Figures by Country
3.6.1 Latin America DTaP and Tdap Vaccines Sales by Country
3.6.2 Latin America DTaP and Tdap Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa DTaP and Tdap Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Country
3.7.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global DTaP and Tdap Vaccines Historic Market Analysis by Type
4.1 Global DTaP and Tdap Vaccines Sales Market Share by Type (2016-2021)
4.2 Global DTaP and Tdap Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global DTaP and Tdap Vaccines Price by Type (2016-2021)

5 Global DTaP and Tdap Vaccines Historic Market Analysis by Application
5.1 Global DTaP and Tdap Vaccines Sales Market Share by Application (2016-2021)
5.2 Global DTaP and Tdap Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global DTaP and Tdap Vaccines Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Pasteur Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GlaxoSmithKline Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Protein Sciences Corporation
6.3.1 Protein Sciences Corporation Corporation Information
6.3.2 Protein Sciences Corporation Description and Business Overview
6.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Protein Sciences Corporation Product Portfolio
6.3.5 Protein Sciences Corporation Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis AG Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Seqirus
6.5.1 Seqirus Corporation Information
6.5.2 Seqirus Description and Business Overview
6.5.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Seqirus Product Portfolio
6.5.5 Seqirus Recent Developments/Updates
6.6 Merck Sharp & Dohme Corp
6.6.1 Merck Sharp & Dohme Corp Corporation Information
6.6.2 Merck Sharp & Dohme Corp Description and Business Overview
6.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Merck Sharp & Dohme Corp Product Portfolio
6.6.5 Merck Sharp & Dohme Corp Recent Developments/Updates
6.7 Astellas Pharma US, Inc
6.6.1 Astellas Pharma US, Inc Corporation Information
6.6.2 Astellas Pharma US, Inc Description and Business Overview
6.6.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Astellas Pharma US, Inc Product Portfolio
6.7.5 Astellas Pharma US, Inc Recent Developments/Updates
6.8 Pfizer Inc
6.8.1 Pfizer Inc Corporation Information
6.8.2 Pfizer Inc Description and Business Overview
6.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Pfizer Inc Product Portfolio
6.8.5 Pfizer Inc Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Corporation Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Johnson & Johnson Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Lanzhou Institute of Biological Products Co., Ltd
6.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
6.10.2 Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
6.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Lanzhou Institute of Biological Products Co., Ltd Product Portfolio
6.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
6.11 AstraZeneca
6.11.1 AstraZeneca Corporation Information
6.11.2 AstraZeneca DTaP and Tdap Vaccines Description and Business Overview
6.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 AstraZeneca Product Portfolio
6.11.5 AstraZeneca Recent Developments/Updates
6.12 Emergent BioSolutions Inc
6.12.1 Emergent BioSolutions Inc Corporation Information
6.12.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Description and Business Overview
6.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Emergent BioSolutions Inc Product Portfolio
6.12.5 Emergent BioSolutions Inc Recent Developments/Updates

7 DTaP and Tdap Vaccines Manufacturing Cost Analysis
7.1 DTaP and Tdap Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of DTaP and Tdap Vaccines
7.4 DTaP and Tdap Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 DTaP and Tdap Vaccines Distributors List
8.3 DTaP and Tdap Vaccines Customers

9 DTaP and Tdap Vaccines Market Dynamics
9.1 DTaP and Tdap Vaccines Industry Trends
9.2 DTaP and Tdap Vaccines Growth Drivers
9.3 DTaP and Tdap Vaccines Market Challenges
9.4 DTaP and Tdap Vaccines Market Restraints

10 Global Market Forecast
10.1 DTaP and Tdap Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of DTaP and Tdap Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of DTaP and Tdap Vaccines by Type (2022-2027)
10.2 DTaP and Tdap Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of DTaP and Tdap Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of DTaP and Tdap Vaccines by Application (2022-2027)
10.3 DTaP and Tdap Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of DTaP and Tdap Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of DTaP and Tdap Vaccines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer